Arkadios Wealth Advisors Dyne Therapeutics, Inc. Transaction History
Arkadios Wealth Advisors
- $3.83 Billion
- Q3 2025
A detailed history of Arkadios Wealth Advisors transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 10,104 shares of DYN stock, worth $234,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,104Holding current value
$234,210% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
122MCall Options Held
36.5KPut Options Held
74.3K-
Ra Capital Management, L.P. Boston, MA9.71MShares$225 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$219 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$212 Million19.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.65MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$171 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.2B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...